Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study
- PMID: 25447599
- DOI: 10.1016/j.jneuroim.2014.09.021
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study
Abstract
Circulating Pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) levels were measured longitudinally (mean follow-up 2 years) by ELISA in 6 patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes (POEMS) syndrome and 16 controls. Expression of PTX3 was also assessed (immunohistochemistry) on sural nerve biopsies from POEMS and vasculitic neuropathy patients. No correlation was found between PTX3 and VEGF levels in POEMS or controls. Sural nerve biopsies from vasculitic neuropathy patients, but not those from POEMS syndrome, showed strong PTX3 staining. PTX3, expression of vessel inflammation/remodeling, and VEGF, crucial pro-angiogenic cytokine, appear to be independently regulated in POEMS syndrome.
Keywords: POEMS syndrome; Pentraxin 3; Polyneuropathy; Vascular endothelial growth factor (VEGF); Vasculitis.
Copyright © 2014 Elsevier B.V. All rights reserved.
Comment in
-
Evaluation of pentraxin-3 in POEMS syndrome.J Neuroimmunol. 2015 Jan 15;278:136. doi: 10.1016/j.jneuroim.2014.12.015. Epub 2014 Dec 19. J Neuroimmunol. 2015. PMID: 25595262 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous